PATTI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 22.034
AS - Asia 9.424
EU - Europa 8.051
SA - Sud America 2.219
AF - Africa 857
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 17
AN - Antartide 1
Totale 42.626
Nazione #
US - Stati Uniti d'America 21.197
SG - Singapore 4.317
CN - Cina 3.670
IE - Irlanda 2.453
BR - Brasile 1.951
UA - Ucraina 1.703
IT - Italia 1.542
CA - Canada 757
RU - Federazione Russa 640
CI - Costa d'Avorio 534
DE - Germania 420
KR - Corea 370
VN - Vietnam 363
SE - Svezia 289
IN - India 206
GB - Regno Unito 203
FI - Finlandia 196
SN - Senegal 145
FR - Francia 123
AR - Argentina 89
BD - Bangladesh 81
CH - Svizzera 79
NL - Olanda 79
AT - Austria 73
PL - Polonia 68
ZA - Sudafrica 61
EC - Ecuador 57
TR - Turchia 49
UZ - Uzbekistan 49
MX - Messico 44
VE - Venezuela 38
HK - Hong Kong 37
IQ - Iraq 37
GR - Grecia 36
PK - Pakistan 32
ES - Italia 30
CZ - Repubblica Ceca 29
ID - Indonesia 29
JP - Giappone 29
LB - Libano 29
NG - Nigeria 25
MA - Marocco 23
BG - Bulgaria 22
EU - Europa 21
TN - Tunisia 20
CO - Colombia 19
PY - Paraguay 19
SA - Arabia Saudita 19
CL - Cile 18
EG - Egitto 16
BE - Belgio 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
KE - Kenya 13
NP - Nepal 13
PE - Perù 13
AZ - Azerbaigian 11
JO - Giordania 10
LT - Lituania 10
HR - Croazia 8
IL - Israele 8
UY - Uruguay 8
DZ - Algeria 7
HN - Honduras 6
IR - Iran 6
RO - Romania 6
KZ - Kazakistan 5
OM - Oman 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
CG - Congo 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
KG - Kirghizistan 4
PA - Panama 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
GT - Guatemala 3
PS - Palestinian Territory 3
RS - Serbia 3
SI - Slovenia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 42.596
Città #
Dallas 5.191
Santa Clara 2.528
Singapore 2.492
Dublin 2.440
Chandler 2.051
Jacksonville 1.845
Boardman 1.044
Hefei 872
Nanjing 713
Cambridge 663
Lawrence 662
Andover 649
Ashburn 616
Chicago 560
Toronto 556
Abidjan 534
Catania 385
Seoul 369
Des Moines 331
Houston 265
San Mateo 257
Wilmington 238
Beijing 227
Nanchang 220
Civitanova Marche 196
Munich 187
Los Angeles 183
Shenyang 179
Hebei 161
Ottawa 150
Saint Petersburg 149
Dakar 145
Jiaxing 136
Changsha 135
São Paulo 133
Tianjin 132
Helsinki 114
Ho Chi Minh City 100
Council Bluffs 80
Pune 72
Hanoi 70
Dong Ket 69
Moscow 68
Bremen 67
Grafing 63
Lappeenranta 62
New York 60
Rio de Janeiro 57
Norwalk 54
San Francisco 53
The Dalles 52
Columbus 51
Milan 51
Jinan 49
Seattle 49
Rome 48
Washington 47
Belo Horizonte 43
Brasília 42
Zhengzhou 40
Brooklyn 35
London 34
Hangzhou 33
Ningbo 33
Warsaw 33
Hong Kong 32
Palermo 32
Phoenix 32
Porto Alegre 32
Den Haag 31
Guangzhou 29
Johannesburg 29
Curitiba 28
Stockholm 28
Kunming 27
Boston 26
Chennai 24
Frankfurt Am Main 23
Guarulhos 23
Naples 23
Tokyo 23
Abuja 22
Liberty Lake 22
Salvador 22
Ann Arbor 20
Campinas 20
Padova 20
Taizhou 20
Dhaka 19
Goiânia 19
Amsterdam 18
Charlotte 18
Mascalucia 18
Mumbai 18
Atlanta 17
Baghdad 17
Guayaquil 17
Montreal 17
Nuremberg 17
Porcari 17
Totale 30.023
Nome #
A case of multiple autoimmunity complicated by SIADH 254
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study 235
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 185
Management of dysphagia in multiple sclerosis: current best practice 125
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 110
Altered time course of changes in the hippocampal concentration of excitatory and inhibitory amino acids during kainate-induced epilepsy 108
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 108
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement 104
"Valutazione della efficacia terapeutica di un derivato benzamidico (Tiapride) in alcune sindromi di interesse neurologico". 102
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 101
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 101
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal. 100
Cognitive dysfunction in multiple sclerosis. A population based study in Catania, Sicily 99
Epilepsy and multiple sclerosis 98
An update on the safety of treating relapsing-remitting multiple sclerosis 98
Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study 97
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 96
Neurophysiological tests in Multiple Sclerosis. A synthetic overview. 95
The Rao's Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population 94
Cognitive impairment and "invisible symptoms" are not associated with CCSVI in MS 93
"BoNT/A treatment of Sialorrohea following neurological disorders 92
A case of Marburg variant multiple sclerosis: clinical impact after high dose cyclophosphamide treatment 92
"Effetti della somministrazione cronica di Aloperidolo e Sulpiride sul contenuto di GABA nella Substantia Nigra del ratto". 92
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated 92
Can new chemical therapies improve the management of multiple sclerosis in children? 91
Analisi del cammino di bambini con paralisi cerebrale infantile: modificazioni della cinetica della caviglia dopo trattamento con tossina botulinica di tipo A 91
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 91
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 90
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 90
Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy 90
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update 89
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 88
"Influenza del sistema dopaminergico centrale sulla attivita' GABAergica del cervelletto". 88
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 88
A waves in electroneurography: differential diagnosis with other late responses 87
The impact of outpatient rehabilitation on quality of life in multiple sclerosis 86
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 86
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 86
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 86
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review 85
Calcitonin and migraine 85
MULTIDISCIPLINARY APPROACH OF AMYOTROPHICLATERAL SCLEROSIS:A CENTRE EXPERIENCE 85
"Comparative effects of estrogens and Prolactin on nigro-striatal DAergic system: neurochemical and behavioral findings". 85
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 85
Effects of Zn++ sulphate on limbic motor seizures indiced by kainic acid [Effetti del solfato di zinco sulla epilessia motoria limbica indotta da acido Kainico] 85
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 85
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 85
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 85
CCSVI and MS. A population-based case-control study in Catania, Sicily. 84
Possible increasing risk of multiple sclerosis in Catania, Sicily 83
When the word doesn't come out: A synthetic overview of dysarthria 83
Palliative care in progressive multiple sclerosis 83
"Modulazione del sistema dopaminergico nigro-striatale da parte di estrogeni e Prolattina: dati comportamentali e neurochimici". 83
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 83
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 83
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 83
"Valutazione del behaviour motorio in condizioni di iperprolattinemia". 82
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily. 82
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry 81
Epilepsy and multiple sclerosis in Sicily: a population-based study 81
Cognitive dysfunction in multiple sclerosis [Deficit delle funzioni corticali superiori nella sclerosi multipla] 81
Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study 81
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 81
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 81
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 81
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 81
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 80
"Calcitonina and nigro-striatal system: neurochemical, behavioural and clinical data". 80
Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case control study 80
An update on the pharmacological management of pain in patients with multiple sclerosis 80
Determinants of sexual impairment in multiple sclerosis in male and female patients with lower urinary tract dysfunction: results from an italian cross-sectional study. 79
"Convulsioni sperimentali indotte da iniezioni di acido Kainico nei nuclei cerebellari". 79
Oral drugs in multiple sclerosis therapy: An overview and a critical appraisal 79
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data 78
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study 78
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study 78
"La distonia: correlazione tra blink reflex e trattamento farmacologico con Reserpina". 78
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impariment in Multiple Sclerosis (COGIMUS) study 78
Italian Validation of the 12-Item Multiple Sclerosis Walking Scale 78
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 78
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 77
Aminoacid concentration in ante-mortem and post-mortem wounds 77
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study 77
Osteoporotic vertebral compression fracture pain (back pain): Our experience with balloon kyphoplasty. [Dolore da fratture vertebrali osteoporotiche (mal di schiena): Nostra esperienza con la cifoplastica] 77
Clinical Evolution of Relapsing Remitting Late Onset Multiple Sclerosis: A Nine Year Follow-Up Study 77
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 77
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily 77
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 77
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 76
The Italian Multiple Sclerosis Register Experience With Cladribine 76
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 76
Ruolo terapeutico della carbissimetilcellulosa 0.5% e soluti compatibili sulla superficie oculare del soggetto con sclerosi multipla 76
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide 76
"Comparative effect of chronic Haloperidol and Sulpiride treatment on nigral and striatal GABA content". 76
Frequency of celiac disease is not increased among multiple sclerosis patients 76
Wegener’s Granulomatosis Presenting as An Intracranial Hypertension Syndrome Treated with High Dose of Cyclophosphamide 76
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS 76
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 76
Paediatric multiple sclerosis: A scoping review of patients’ and parents’ perspectives 76
"Calcitonin effects on extrapyramidal system: clinical and experimenta data". 75
Totale 8.970
Categoria #
all - tutte 174.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.394 0 0 0 29 995 80 328 15 307 36 412 192
2021/20224.526 558 699 30 87 709 17 688 143 364 12 154 1.065
2022/20237.045 704 208 103 497 721 1.258 34 1.246 1.852 61 263 98
2023/20242.845 179 422 154 164 115 461 80 168 33 95 625 349
2024/202511.706 99 1.585 823 382 2.365 1.067 345 521 1.097 1.534 794 1.094
2025/20269.773 1.541 2.240 4.934 1.058 0 0 0 0 0 0 0 0
Totale 43.782